Heritable Disorders

CFDA 93.683 Active Grant Cooperative Agreement

Program Funding

Annual program obligations reported to SAM.gov.

Latest annual funding
$15.7M FY2025
$15.8M
FY24
$15.7M
FY25

Funded Projects

Examples of what this program has supported.

FY2025 Most states and U.S.-affiliated territories receive funding to improve newborn screening and add conditions to their state newborn screening panels. As of December 2024, all states (as well as Washington D.C., Guam, and Puerto Rico) screen for at least 31 of the 38 core conditions on the Recommended Uniform Screening Panel (RUSP), with 41 states screening for at least 35 of the 38.



States continue to engage in quality improvement activities to improve their screening and provision of newborn screening results to providers and families to decrease the time to confirmation of a diagnosis. 76% states collect 95% or more of newborn screening specimens within 48 hours of birth so that early testing and identification can occur and results are shared quickly so that providers can diagnose and begin treatment.
FY2026 Most states and U.S.-affiliated territories receive funding to improve newborn screening and add conditions to their state newborn screening panels. As of December 2024, all states (as well as Washington D.C., Guam, and Puerto Rico) screen for at least 31 of the 38 core conditions on the Recommended Uniform Screening Panel (RUSP), with 41 states screening for at least 35 of the 38.



States continue to engage in quality improvement activities to improve their screening and provision of newborn screening results to providers and families to decrease the time to confirmation of a diagnosis. 76% states collect 95% or more of newborn screening specimens within 48 hours of birth so that early testing and identification can occur and results are shared quickly so that providers can diagnose and begin treatment.

Program Objective

The Heritable Disorders program serves to improve the ability of States 1) to provide newborn and child screening for heritable disorders and 2) to expand screenings as the capacity to screen for genetic and congenital conditions expands Newborn and child screenings occur at intervals across the life span of every child. Newborn screening universally provides early identification and follow-up for treatment of infants affected by certain genetic, metabolic, hormonal and/or functional conditions.

Eligibility

Eligible Applicants

  • U.S. State Government
  • Local
  • Other

Eligible entities for the Heritable Disorders Program include a State or a political subdivision of a State; a consortium of two or more States of political subdivisions of States; a territory; a health facility or program operated by or pursuant to a contract with or grant from the Indian Health Service; or any other entity with appropriate expertise in newborn screening, as determined by the Secretary.

How to Apply

Award Procedure

All qualified applications will be forwarded to an objective review committee. Based on the recommendations of the objective review committee, the HRSA program official with delegated authority is responsible for final selection and funding decisions. Notification is made in writing by a Notice of Award.

Decision Timeline

  • Approval: From 120 to 180 days

Final decisions are made 4 to 6 months after receipt of applications.

Program details & compliance

Description

The Heritable Disorders program serves to improve the ability of States 1) to provide newborn and child screening for heritable disorders and 2) to expand screenings as the capacity to screen for genetic and congenital conditions expands Newborn and child screenings occur at intervals across the life span of every child. Newborn screening universally provides early identification and follow-up for treatment of infants affected by certain genetic, metabolic, hormonal and/or functional conditions.

Mission Categories

Primary: Maternity, Infants, Children

Use of Funds

Allowed Uses

Heritable Disorders grants are made to improve the ability of States to provide newborn and child screening for heritable disorders, coordinate services and long-term follow-up for newborns and children identified with a condition through newborn screening, and to provide newborn screening education resources to patients, parents, families, and providers.

Restrictions

Funds can not be used for direct services.

Required Documentation

Applicants should review the individual HRSA notice of funding opportunity issued under this Assistance Listing for any required proof or certifications which must be submitted prior to or simultaneous with submission of an application package. 2 CFR 200, Subpart E - Cost Principles applies to this program.

Matching Requirements

Other Opportunities may include matching requirements. Please refer to the notice of funding opportunity.

Reporting & Compliance

Audit Required
Yes — Determined at Time of Award
Records Retention
3 years

Applicable 2 CFR 200 Subparts

  • Subpart B — General Provisions
  • Subpart C — Pre-Federal Award Requirements
  • Subpart D — Post-Federal Award Requirements
  • Subpart E — Cost Principles
  • Subpart F — Audit Requirements

Contacts

Eliza Heppner, Acting Associate Administrator for Maternal and Child Health
301-443-2170
5600 Fishers Lane, Rockville, MD 20857
Data from SAM.gov Federal Assistance Listings. Source published: 2026-01-09. Spec v2.0. Last synced: 2026-05-30 02:30:47.